A campaign production has been designed for a flexible production of:
Lyophilizates: Up to 1 500 vials / 2 ml
- Sterile lyophilizates
- Non-sterile lyophilizates
Liquids and aseptic filling
- Non-sterile liquid formulations
- Monodoses (500–1000 strips)
10:30-11.00
Being a Good Guest: the Host Implant Paradigm
11:30 - 11:50
Translational Research in Early Development: Pitfalls, gaps and some practical solutions
11:50 – 12:10
Translational aspects of Nanopharmaceuticals for Ocular Delivery
12:10 - 12:30
Moving Nanobiotechnology from the Lab to the Market
12:30 – 12:50
Application of sophisticated micelles and nanogels in drug delivery: challenges and opportunities
12:50 – 13:20
Single Chain Nanoparticles towards regulation compliance
15:00-15:20
Concept of Microfluidics for Chemical production Dr. Thomas R. Dietrich (IVAM, Germany)
15:20-15:40
On-line and in-line quality control for nanomanufacturing
15:40-16:00
Continuous Flow Processing: Scalability, Advantages & Challenges for Manufacturing in the Pharmaceutical Industry
16:00-16:20
Development of a Micro-mixing Pilot Line for the Continuous Production of Glycan Coated Nanoparticles
17:00-17:20
Challenges in the journey from research to final drug product.
17:20-17:40
From lab procedures to a pilot plant under GMP. An obstacle race
17:40- 18:00
Bridging early academic research & clinical development on polypeptide-based nanomedicines
18:00-18:20
Synthesis and characterization of functional hyaluronic acid conjugates for biomedical applications
The ETPN Nanomedicine Translation Hub
9:00-9:20
Analytical developments for the characterization of nanomedicine; From raw materials to nanoformulations.
9:20-9:40
Overcoming challenges in biophysical characterization of Nanopharmaceuticals
9:40-10:00
Radiochemistry and nuclear imaging: application to the in vivo investigation of nanomaterials
10:00-10:20
Physical-Chemical Characterization of Nanomedicines
10:20-10:40
Nanocharacterization: what is still missing to improve translation in nanomedicine
11:10-11:30
Regulatory Science approaches to improve translational research in nanomedicine
11:30 - 11:50
The EudraLex Rules Governing Medicinal Products in the European Union. The Annex 13 about Investigational Medicinal Products
11:50 – 12:10
Regulatory requirements for clinical trials´authorization
12:10 - 12:30
The Spanish Medicines Agency’s Office for support of innovation and knowledge of medicinal products
12:30-13:00
Fighting against cancer stem cells with Nanomedicine
14:30 -15:00
Visit to the facilities
10-15 min visit in small groups
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare,.
Download now
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
National University of Ireland, Galway
Basque Country, one of the regions with the highest rates of progress and well-being standards in Europe and characterized by a solid industrial tradition that currently represents a quarter of its productive endeavour. It also counts on a self-government system that allows it to establish its own economic and fiscal policies.
TOURISM WEBSITE
